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Retinoids inhibit the development of epithelial
tumours in experimental animals (Moon et al.,
1983). The mechanism of this inhibitory action of
the retinoids is not known. However, it is believed
that their action at the cell level may be mediated
by the widely distributed cellular binding proteins
for retinol (CRBP) and' retinoic acid (CRABP) as
the binding affinity of the retinoids for their
respective binding protein parallels their activity in
mnany, though not all, test systems (Chytil & Ong,
1984). There is thus the possibility that the
concentration of the retinoid-binding proteins in a
tumour might reflect the tumour's sensitivity to
retinoids.
Increased concentrations of CRBP and/or
CRABP relative to adjacent normal tissue have
been reported in human cancers of the head and
neck region (Ong et al., 1982), breast (Kung et al.,
1980) and uterine cervix (Palan & Romney, 1980).
In liver cancer CRABP concentration but not
CRBP concentration was increased compared to
normal tissue (Ikezaki et al., 1985) and in prostatic
cancer tissue the level of CRBP was decreased
relative to hyperplastic tissue (Boyd et al., 1985).
In colon cancer Palan et al. (1980) reported
elevated CRBP concentration in the tumour
compared with adjacent normal tissue in four men,
but not in five women in the same study. A similar
sex difference was found for CRABP. High
concentrations of CRBP but not of CRABP have
also been demonstrated in DMH-induced rat colon
adenocarcinoma (Ong et al., 1978). All the above
studies were performed using a ligand-binding assay
for CRBP and CRABP. This method has several
drawbacks. It is complicated, relatively non-specific
and insensitive and has been shown to
underestimate the levels of the respective binding
protein (Ong et al., 1982).
In the present report we have determined the
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concentration of CRBP in normal human colon
and in colon adenocarcinoma from the same
individual in a larger patient series using a sensi-
tive and specific radioimmunoassay (Fex &
Johnannesson, 1984) and related the results to
tumour localization, size, Dukes' stage and degree
of differentiation.
The patient material consisted of 13 males and 30
females, aged 47-85 years. In two cases (two female
patients) with benign tumours only the normal
colon tissue data were included in the calculations.
The degree of differentiation, localization and
Dukes' stage of the tumours in the patients is
shown in Table I.
Tissue specimens of the tumours, macroscopically
free of necrosis and of apparently normal tissue
from adjacent mucosa were cut out by the surgeon
in conjunction with the resection. The specimens
were immediately frozen at -20°C and kept frozen
until analysis, which was performed within 4 weeks.
The samples were then thawed and the normal
colon cut into full thickness pieces perpendicular to
the mucosal plane ('whole normal colon') or
dissected into mucosa plus submucosa ('mucosa')
and muscularis propria plus serosa ('muscularis')
respectively. Homogenization and radioimmuno-
logical determination of CRBP was performed
exactly as described (Fex & Johannesson,
1984). The total coefficient of variation calculated
from the results for a control (20jg CRBP1-1)
included in each analytical run was 17% (26 runs,
2 controls/run) which, in our experience is
reasonable for a routine radioimmunoassay.
Protein was determined according to Bradford
(1976) using bovine serum albumin as calibration
standard. All tumours were adenocarcinomas. Histo-
pathological classification was performed according
to Ackerman & Del Regato (1947). Nonparametric
tests (Wilcoxon-Mann-Whitney test and Spearman's
rho) were used for the statistical treatment
of the data.
Dilutions of the tissue extracts of the tumours
displaced the CRBP standard in a similar way as
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Table I Characteristics of the patient material (14 male and 27 female patients aged 47-85 years). Two cases with benign
tumours are included in the table.
Localization Stage according to Dukes
Degree of
differentiation Ascendens Trasversum Sigmoideum Rectum A B C
High 2 2 4 1 5 2
Intermediate 5 3 5 10 5 9 9
Low 5 4 1 5 5
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Figure 1 Radioimmunoassay standard curve for
human liver CRBP (0) and displacement of 125-I-
CRBP by dilutions of colon cancer extracts (A). The
X-axis gives the CRBP concentration in the respective
standards. The Y-axis gives the percent antibody-
bound 125-I-radioactivity expressed as percent of the
zero standard. With the antibody dilution used for the
assay, 50-65% of the tracer was bound in the zero
standard.
purified CRBP (Figure 1) indicating that an
antigenically similar CRBP was present in the
tumour tissue extract. Similar deplacement curves
were obtained with extracts from normal colonic
tissue.
The CRBP values for whole normal colon
(Figure 2) were, with one exception, scattered in the
interval 18-82/.tgg-' tissue protein. The tumour
CRBP concentrations showed a much larger
variation with values both below and above the
range for whole normal colon. Two benign
tumours, one lipoma and one adenoma contained
34 and 28pg CRBPg-1 tissue protein. As tested
with the Wilcoxon-Mann-Whitney test the CRBP
concentration in the tumour was not significantly
different from that of whole normal colon or
colonic mucosa from the same patient (Figure 2).
There was no sex difference in CRBP concentration
either in whole normal colon or in colon tumours
and there was no difference in CRBP concentration
in samples from whole normal colon or colon
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Figure 2 Scatter diagram of CRBP concentration
(pgg-1 tissue protein) samples of A: whole normal
colon (9 males, 16 females), B: colon
mucosa+submucosa (5 males, 13 females), C: colon
muscularis+serosa (5 males, 13 females) and D: colon
tumour (13 males, 28 females). The values (median
and range) in males and females for whole normal
colon were 33, 19-184 (males); 51, 22-88 (females) and
for colon tumours 44, 7-126 (males); 46, 12-791
(females). The median is indicated with a horizontal
line.
tumours from different parts of the colon.
However, the CRBP concentration in the tumour
was significantly higher than in the muscularis of
normal colon (P<0.05, concentration ratio (median
and range): 1.46; 0.39-3.67; N= 18). The CRBP
concentration in normal mucosa was also
significantly higher than in normal muscularis of
the same patient (P<0.05, concentration ratio
(median and range): 1.57; 0.47-2.69; N= 18). Thus,
the mucosal cells are richer in CRBP than the other
cells of the colon wall.CRBP IN COLORECTAL CARCINOMA 689
The absolute values for the CRBP concentration
in whole normal colon obtained in this study were
similar to the figures obtained previously using
necropsy material (Fex & Johannesson, 1984).
Thus, results obtained with necropsy material are
close to the values obtained with fresh tissue which
indicates that in the colon, CRBP is relatively
insensitive to proteolysis post mortem.
The concentration of CRBP in the tumour
correlated significantly to the concentration in
whole normal colon (rho=0.46; P<0.05; N=23).
Whether this means that tumours with high CRBP
concentration arise in areas of normal colon with
high CRBP concentration or that tumours with
high CRBP concentration in some way increase the
CRBP concentration of adjacent normal colon is
unknown.
The CRBP concentration in both whole normal
colon and in the tumours varied over a wide range
(Figure 2). The reason for this wide variation is
unknown. Among possible contributing causes is
heterogeneity within the tumour. There may also be
subgroups of tumours which are richer in CRBP
than others but which cannot be identified as such
at present. We have carefully gone through the four
cases which had very high (>100pgg-1) CRBP
concentration in whole normal colon and/or colon
tumour, without being able to find anything unique
about them. To 'correct' the tumour CRBP values
for the possible influence of differences in the
CRBP concentration of the surrounding normal
colon, individual ratios of tumour CRBP
concentration and CRBP concentration of whole
normal colon, mucosa and muscularis were
calculated.
The CRBP concentration ratio tumour/whole
normal colon showed significant statistical
correlation with the degree of differentiation of the
tumour (rho=0.54; P<0.05; N=23). Thus, in
highly differentiated tumours the difference in
CRBP concentration between whole normal colon
and tumour tends to be higher than in cases with
less well differentiated tumours. Whether this
means that high CRBP concentration is related to
the well differentiated state or that a normal colon
with low CRBP concentration more often gives rise
to highly differentiated tumours is presently
unknown. The demonstration of increased concen-
tration in differentiated as compared with
undifferentiated F9 cells (Eriksson, 1984) lends
some support to the former explanation.
The CRBP concentration ratio mucosa/mucularis
showed significant negative correlation to patient
age (rho= -0.58; P<0.05; N= 18) suggesting that
the CRBP concentration in these two layers
becomes more similar with advancing age.
It is evident (Figure 2) that our results from a
larger patient series are in contrast to the findings
of Palan et al. (1980) since we do not find
significantly increased CRBP concentration in colon
tumours compared to whole normal colon from the
same patient and no sex difference either in whole
normal colon or in colon tumours. Our data are
also in contrast to the findings in DMH-induced
rat colon adenocarcinoma (Ong et al., 1978).
Though a direct comparison of absolute values is
difficult to make, due to methodological differences,
it can be approximately calculated that the results
from normal human colon and colon cancer
reported by Palan et al. (1980) are about one order
of magnitude lower than our figures while the
figures of Ong et al. (1978) for normal rat colon
and colon cancer are more comparable with ours.
The reason for the discrepancy between our data
and those of Palan et al. (1980) is probably the
limited number of patients in their study and the
low specificity and sensitivity of their assay. Our
data are also at variance with the studies on DMH-
induced rat colon adenocarcinoma (Ong et al.,
1978). The reason for this may be that, apart from
methodological and species differences, the DMA-
induced cancers may constitute a more homo-
geneous tumour group than the tumours in our
patients. It may well be that, in man also, there are
subgroups of tumours which have higher or lower
CRBP concentration than adjacent normal mucosa
but, at present, there are no ways of identifying
them as such.
Several epidemiological studies have suggested a
relationship between vitamin A intake and cancer
incidence and between the levels of serum retinol
and later cancer development (Willett &
MacMahon, 1984). The strongest relationship has
been found with lung cancer. Studies aimed at
finding such a relationship between colon cancer
and vitamin A intake (Modan et al., 1981) or low
serum retinol (Nomura et al., 1985) have, however,
been negative. Whether this is in any way related to
the lack of difference in CRBP concentration
between normal colon and colon cancers is
unknown.
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